AUS
NZ
UK
CA
USA
IND
In the consumer sector, Dr. Martens plc has attracted attention due to its current valuation. Recent calculations using the Discounted Cash Flow (DCF) model suggest that the company's fair value is estimated at £1.31 per share. With the current share price at £0.72, this indicates a potential undervaluation of approximately 45%. Furthermore, the target price set by analysts for Dr. Martens is £0.78, which is about 41% lower than the fair value estimate.
Valuation Methodology
The DCF model was utilized to estimate the value of Dr. Martens (LSE:DOCS). This model involves projecting the company's future cash flows and discounting them to their present value. Specifically, the 2-stage growth model was applied, which consists of two phases: an initial high-growth period followed by a phase of stable growth.
To determine the company's value, the present value of the cash flows expected over the next decade was calculated. This involved discounting the estimated future cash flows at a rate of 9.1%, which results in a present value of £630 million.
Terminal Value Calculation
To account for the value of cash flows beyond the initial ten-year period, the terminal value was calculated using the Gordon Growth formula. This calculation used a long-term growth rate of 1.9% and was discounted at the same rate of 9.1%. The terminal value amounted to £1.5 billion, and its present value is £632 million.
Total Equity Value
Adding the present value of the ten-year cash flows to the present value of the terminal value provides the total equity value of £1.3 billion. When divided by the total number of shares outstanding, this results in an intrinsic value per share of £1.31. Compared to the current share price of £0.72, this valuation suggests that the shares are trading at a significant discount.
Final Considerations
The DCF model is a useful tool for assessing valuation but relies on assumptions, such as the discount rate and future cash flow projections. It does not account for potential industry cyclicality or future capital needs, which may impact the accuracy of the valuation. As such, while the model indicates a potential undervaluation, it is important to consider these factors when interpreting the results.
